93 related articles for article (PubMed ID: 28734109)
1. The cost of oropharyngeal cancer in England: A retrospective hospital data analysis.
Keeping ST; Tempest MJ; Stephens SJ; Carroll SM; Simcock R; Jones TM; Shaw R
Clin Otolaryngol; 2018 Feb; 43(1):223-229. PubMed ID: 28734109
[TBL] [Abstract][Full Text] [Related]
2. Cost-identification analysis in oral cavity cancer management.
Funk GF; Hoffman HT; Karnell LH; Ricks JM; Zimmerman MB; Corbae DP; Hussey DH; McCulloch TM; Graham SM; Dawson CJ; Means ME; Colwill ML; Titler MG; Smith EM
Otolaryngol Head Neck Surg; 1998 Feb; 118(2):211-20. PubMed ID: 9482555
[TBL] [Abstract][Full Text] [Related]
3. The effect of hospital safety-net burden status on short-term outcomes and cost of care after head and neck cancer surgery.
Genther DJ; Gourin CG
Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1015-22. PubMed ID: 23165375
[TBL] [Abstract][Full Text] [Related]
4. Cost considerations in the treatment of oropharyngeal squamous cell carcinoma.
Moore EJ; Hinni ML; Olsen KD; Price DL; Laborde RR; Inman JC
Otolaryngol Head Neck Surg; 2012 Jun; 146(6):946-51. PubMed ID: 22344182
[TBL] [Abstract][Full Text] [Related]
5. Annual cost of hospitalization, inpatient rehabilitation and sick leave of anal cancer in Germany.
Heitland W; Schädlich PK; Chen X; Rémy V; Moro L
J Med Econ; 2013; 16(3):364-71. PubMed ID: 23253056
[TBL] [Abstract][Full Text] [Related]
6. Penile cancer treatment costs in England.
Keeping ST; Tempest MJ; Stephens SJ; Carroll SM; Sangar VK
BMC Public Health; 2015 Dec; 15():1305. PubMed ID: 26715043
[TBL] [Abstract][Full Text] [Related]
7. The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales.
McGuire A; Irwin DE; Fenn P; Gray A; Anderson P; Lovering A; MacGowan A
Value Health; 2001; 4(5):370-5. PubMed ID: 11705127
[TBL] [Abstract][Full Text] [Related]
8. The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-up.
van Agthoven M; van Ineveld BM; de Boer MF; Leemans CR; Knegt PP; Snow GB; Uyl-de Groot CA
Eur J Cancer; 2001 Nov; 37(17):2204-11. PubMed ID: 11677108
[TBL] [Abstract][Full Text] [Related]
9. Direct healthcare costs of lip, oral cavity and oropharyngeal cancer in Brazil.
Milani V; Zara ALSA; da Silva EN; Cardoso LB; Curado MP; Ribeiro-Rotta RF
PLoS One; 2021; 16(2):e0246475. PubMed ID: 33596233
[TBL] [Abstract][Full Text] [Related]
10. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
11. CE: Human Papillomavirus-Related Oropharyngeal Cancer: A Review of Nursing Considerations.
McKiernan J; Thom B
Am J Nurs; 2016 Aug; 116(8):34-43. PubMed ID: 27428508
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and impact of complications on outcomes in patients hospitalized for oral and oropharyngeal cancer treatment.
Lee MK; Nalliah RP; Kim MK; Elangovan S; Allareddy V; Kumar-Gajendrareddy P; Allareddy V
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Nov; 112(5):581-91. PubMed ID: 22035652
[TBL] [Abstract][Full Text] [Related]
13. The effect of transoral robotic surgery on short-term outcomes and cost of care after oropharyngeal cancer surgery.
Richmon JD; Quon H; Gourin CG
Laryngoscope; 2014 Jan; 124(1):165-71. PubMed ID: 23945993
[TBL] [Abstract][Full Text] [Related]
14. Years of potential life lost and productivity costs because of cancer mortality and for specific cancer sites where human papillomavirus may be a risk factor for carcinogenesis-United States, 2003.
Ekwueme DU; Chesson HW; Zhang KB; Balamurugan A
Cancer; 2008 Nov; 113(10 Suppl):2936-45. PubMed ID: 18980277
[TBL] [Abstract][Full Text] [Related]
15. Lifetime health care costs of oropharyngeal cancer for commercially insured patients in the United States.
Wu CF; Lairson DR; Dahlstrom KR; Fokom Domgue J; Fu S; Sturgis EM; Chan W
Head Neck; 2020 Sep; 42(9):2321-2329. PubMed ID: 32359131
[TBL] [Abstract][Full Text] [Related]
16. Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck.
Lang K; Sussman M; Friedman M; Su J; Kan HJ; Mauro D; Tafesse E; Menzin J
Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):582-8. PubMed ID: 19528407
[TBL] [Abstract][Full Text] [Related]
17. An analysis of surgical complications, morbidity, and cost calculation in patients undergoing multimodal treatment for operable oropharyngeal carcinoma.
Preuss SF; Quante G; Semrau R; Mueller RP; Klussmann JP; Guntinas-Lichius O
Laryngoscope; 2007 Jan; 117(1):101-5. PubMed ID: 17135978
[TBL] [Abstract][Full Text] [Related]
18. Economic Burden of Bladder Cancer Across the European Union.
Leal J; Luengo-Fernandez R; Sullivan R; Witjes JA
Eur Urol; 2016 Mar; 69(3):438-47. PubMed ID: 26508308
[TBL] [Abstract][Full Text] [Related]
19. Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer.
Givens DJ; Karnell LH; Gupta AK; Clamon GH; Pagedar NA; Chang KE; Van Daele DJ; Funk GF
Arch Otolaryngol Head Neck Surg; 2009 Dec; 135(12):1209-17. PubMed ID: 20026818
[TBL] [Abstract][Full Text] [Related]
20. Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experience.
Andrews G; Lango M; Cohen R; Feigenberg S; Burtness B; Mehra R; Ahmed S; Nicolaou N; Gaughan J; Ridge JA
Head Neck; 2011 Oct; 33(10):1433-40. PubMed ID: 21928415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
